Thomas Broeer elected as new BGMA Chairman

Brings more than 20 years of industry experience to the position

The British Generic Manufacturers Association (BGMA) has appointed Thomas Broeer, Managing Director of Kent Pharmaceuticals, as its new Chairman for the next two years.

He replaces Kim Innes, a director with Teva, who will continue for a further year as Vice-Chairwoman of the association.

Broeer brings more than 20 years of international pharmaceutical business management experience to the BGMA role, working both within the generic and branded industries. Before joining Kent Pharmaceuticals earlier this year, he had previously held senior management roles with Mylan in the UK and Germany.

Broeer said: 'There are a number of challenges and issues facing the generics industry as business models evolve, regulations change and new opportunities such as biosimilars emerge. The association has a crucial role in all these and I look forward to playing an important part in representing our views.'

You may also like